FGF2 induces breast cancer growth through ligand‐independent activation and recruitment of ERα and PRBΔ4 isoform to MYC regulatory sequences

Signaling by Steroid Hormones in the 3D Nuclear Space

(2018) François Le Dily et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Therapeutically targeting tumor microenvironment–mediated drug resistance in estrogen receptor–positive breast cancer

(2018) Kevin Shee et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Network analysis of SRC-1 reveals a novel transcription factor hub which regulates endocrine resistant breast cancer

(2018) Alacoque L. Browne et al.   ONCOGENE

Increased High Molecular Weight FGF2 in Endocrine-Resistant Breast Cancer

(2018) Ana Sahores et al.   Hormones & Cancer

Progesterone Receptor Isoform Ratio: A Breast Cancer Prognostic and Predictive Factor for Antiprogestin Responsiveness

(2017) Paola A. Rojas et al.   JNCI-Journal of the National Cancer Institute

Expression of tripartite motif-containing protein 28 in primary breast carcinoma predicts metastasis and is involved in the stemness, chemoresistance, and tumor growth

(2017) Surekha Damineni et al.   TUMOR BIOLOGY

Progesterone Receptor Isoform Ratio: A Breast Cancer Prognostic and Predictive Factor for Antiprogestin Responsiveness

(2017) Paola A. Rojas et al.   JNCI-Journal of the National Cancer Institute

Chromatin Scanning by Dynamic Binding of Pioneer Factors

(2016) Kenneth S. Zaret et al.   MOLECULAR CELL

Progesterone induces progesterone receptor gene ( PGR ) expression via rapid activation of protein kinase pathways required for cooperative estrogen receptor alpha (ER) and progesterone receptor (PR) genomic action at ER/PR target genes

(2016) Caroline H. Diep et al.   STEROIDS

Breast cancer-associated fibroblasts: their roles in tumor initiation, progression and clinical applications

(2016) Aixiu Qiao et al.   Frontiers of Medicine

Genomic agonism and phenotypic antagonism between estrogen and progesterone receptors in breast cancer

(2016) H. Singhal et al.   Science Advances

Inhibition of c-Myc by 10058-F4 induces growth arrest and chemosensitivity in pancreatic ductal adenocarcinoma

(2015) Meng Zhang et al.   BIOMEDICINE & PHARMACOTHERAPY

Deregulated Myc Requires MondoA/Mlx for Metabolic Reprogramming and Tumorigenesis

(2015) Patrick A. Carroll et al.   CANCER CELL

An immunoproteomic approach for characterization of dormancy within Staphylococcus epidermidis biofilms

(2015) Virginia Carvalhais et al.   MOLECULAR IMMUNOLOGY

Arginine methyltransferases as novel therapeutic targets for breast cancer

(2015) A. Morettin et al.   MUTAGENESIS

Progesterone receptor modulates ERα action in breast cancer

(2015) Hisham Mohammed et al.   NATURE

Defining Breast Cancer Intrinsic Subtypes by Quantitative Receptor Expression

(2015) M. C. U. Cheang et al.   ONCOLOGIST

Expression and functionality of histone H2A variants in cancer

(2015) Fátima Liliana Monteiro et al.   Oncotarget

Progestin and antiprogestin responsiveness in breast cancer is driven by the PRA/PRB ratioviaAIB1 or SMRT recruitment to theCCND1andMYCpromoters

(2014) Victoria Wargon et al.   INTERNATIONAL JOURNAL OF CANCER

Progesterone receptor-B enhances estrogen responsiveness of breast cancer cells via scaffolding PELP1- and estrogen receptor-containing transcription complexes

(2014) A R Daniel et al.   ONCOGENE

Inhibitor of MYC identified in a Krohnke pyridine library

(2014) J. R. Hart et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Endogenous Purification Reveals GREB1 as a Key Estrogen Receptor Regulatory Factor

(2013) Hisham Mohammed et al.   Cell Reports

Estrogen Receptor Alpha Mediates Progestin-Induced Mammary Tumor Growth by Interacting with Progesterone Receptors at the Cyclin D1/MYC Promoters

(2012) S. Giulianelli et al.   CANCER RESEARCH

NIH Image to ImageJ: 25 years of image analysis

(2012) Caroline A Schneider et al.   NATURE METHODS

Genome-Wide Progesterone Receptor Binding: Cell Type-Specific and Shared Mechanisms in T47D Breast Cancer Cells and Primary Leiomyoma Cells

(2012) Ping Yin et al.   PLoS One

Non-Overlapping Progesterone Receptor Cistromes Contribute to Cell-Specific Transcriptional Outcomes

(2012) Christine L. Clarke et al.   PLoS One

Interaction between FGFR-2, STAT5, and Progesterone Receptors in Breast Cancer

(2011) J. P. Cerliani et al.   CANCER RESEARCH

Estrogen Induces c-mycGene Expression via an Upstream Enhancer Activated by the Estrogen Receptor and the AP-1 Transcription Factor

(2011) Chunyu Wang et al.   MOLECULAR ENDOCRINOLOGY

The MPA mouse breast cancer model: evidence for a role of progesterone receptors in breast cancer

(2009) Claudia Lanari et al.   ENDOCRINE-RELATED CANCER

Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes

(2009) Joel S. Parker et al.   JOURNAL OF CLINICAL ONCOLOGY

Carcinoma-associated fibroblasts activate progesterone receptors and induce hormone independent mammary tumor growth: A role for the FGF-2/FGFR-2 axis

(2008) Sebastián Giulianelli et al.   INTERNATIONAL JOURNAL OF CANCER